日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD

利用互联定制治疗平台 (CONCURxP) 移动医疗干预提高乳腺癌患者 CDK4/6 抑制剂的依从性:ECOG-ACRIN EAQ221CD 研究方案

Sadigh, Gelareh; Duan, Fenghai; Gareen, Ilana F; Hancock, Judy; Sicks, JoRean D; Thangarajah, Maryanne; Meisel, Jane L; Torres, Mylin A; Ramsey, Scott D; Wolff, Antonio C; Wagner, Lynne I; Carlos, Ruth C; Graetz, Ilana

MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

基于 MRI 的放射组学特征在多中心环境下对导管原位癌进行风险分层(ECOG-ACRIN E4112 试验)

Slavkova, Kalina P; Kang, Ruya; Kazerouni, Anum S; Biswas, Debosmita; Belenky, Vivian; Chitalia, Rhea; Horng, Hannah; Hirano, Michael; Xiao, Jennifer; Corsetti, Ralph L; Javid, Sara H; Spell, Derrick W; Wolff, Antonio C; Sparano, Joseph A; Khan, Seema A; Comstock, Christopher E; Romanoff, Justin; Gatsonis, Constantine; Lehman, Constance D; Partridge, Savannah C; Steingrimsson, Jon; Kontos, Despina; Rahbar, Habib

Using a pre-radiation window to identify potentially active cytotoxic agents in adults with newly diagnosed glioblastoma

利用放射治疗前窗口期识别新诊断为胶质母细胞瘤的成年患者中潜在的活性细胞毒性药物

Bazer, Danielle A; Wolff, Antonio C; Grossman, Stuart A

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study

一项评估紫杉醇单药或联合Pelareorep(加或不加Avelumab)治疗转移性激素受体阳性乳腺癌的II期随机研究:BRACELET-01/PrE0113研究

Clark, Amy S; Zhao, Fengmin; Klein, Paula; Montero, Alberto J; Falkson, Carla; Krill-Jackson, Elisa; Rowland, Kendrith; Sardesai, Sagar; Incorvati, Jason; Dillon, Patrick; Wolff, Antonio C; Trauger, Richard; Heineman, Thomas C; Coffey, Matthew C; Miller, Kathy D

A composite (18)F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)

一种基于 (18)F-FDG PET/CT 和 HER2 组织的复合生物标志物,用于预测 HER2 阳性乳腺癌对新辅助帕妥珠单抗和曲妥珠单抗的反应 (TBCRC026)

Hennessy, Maeve A; Cimino-Mathews, Ashley; Carter, Jodi M; Kachergus, Jennifer M; Ma, Yaohua; Leal, Jeffrey P; Solnes, Lilja B; Abramson, Vandana G; Carey, Lisa A; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C; Wahl, Richard L; Huang, Chiung-Yu; Stearns, Vered; Thompson, E Aubrey; Connolly, Roisin M

System-Level Transformations to Increase Patient Participation in Clinical Trials

通过系统层面的变革来提高患者参与临床试验的积极性

Caston, Nicole E; Deng, Luqin; Williams, Courtney P; Levitan, Emily B; Azuero, Andres; Griffin, Russell; Smith, Karen L; Wolff, Antonio C; Melisko, Michelle E; Shinn, Eileen H; Gallagher, Kathleen; Angove, Rebekah; Wheeler, Stephanie B; Rocque, Gabrielle B

Understanding Associations Between Patient-Level Factors and Participation in a Breast Cancer Clinical Trial

了解患者层面因素与参与乳腺癌临床试验之间的关联

Caston, Nicole E; Deng, Luqin; Williams, Courtney P; Levitan, Emily B; Azuero, Andres; Griffin, Russell; Smith, Karen L; Wolff, Antonio C; Melisko, Michelle E; Shinn, Eileen H; Gallagher, Kathleen; Angove, Rebekah; Wheeler, Stephanie B; Rocque, Gabrielle B

SUN-823 Creation of Educational Resources to Improve Endocrine Fellow Outpatient Curriculum

SUN-823 创建教育资源以改进内分泌专科医生门诊课程

Klugman, Madelyn F; Aboumrad, Maya; Chen, Ruizhe; Marshall, Catherine H; Canzoniero, Jenna V; Wolff, Antonio C; Visvanathan, Kala; Habib, Ukasha; Shih, Helen; Biller, Beverly M K; Tritos, Nicholas A; Dapas, Natalie; Al Mukaddam, Mona; Attallah, Hamdee; Burns, Carrie M; Jones, Robert; Kharlip, Julia; Noelle Kobaly, Kristen; Cardillo, Serena

EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)

EA1211:FDG-PET/CT 中期研究预测 HER2 阳性乳腺癌对新辅助治疗的反应(DIRECT 试验)

Hennessy, Maeve A; Gatsonis, Constantine; Jacene, Heather; Connolly, Roisin M; Burnette, Brian L; Stringer-Reasor, Erica M; Romanoff, Justin; Taurone, Alexander; O'Sullivan, Ciara C; Le-Petross, Huong T; Stearns, Vered; Fowler, Amy M; Tang, Shou-Ching; Sepulveda, Karla A; DeMichele, Angela M; Mankoff, David A; Wolff, Antonio C